Basel, March 20, 2014-Novartis has announced the launch of the Lucentis ® (ranibizumab) pre-filled syringe (PFS) in Germany, with other markets to follow throughout 2014. The Lucentis PFS ...

Switzerland's Roche Holding AG RO.EB said Thursday that the U.S. Food and Drug Administration has approved its Lucentis 0.3 mg prefilled syringe as a treatment for all forms of diabetic retinopathy.

Lucentis comes as a liquid solution that’s injected into your eye by your doctor. The drug comes in both vials and prefilled syringes. Lucentis comes in two strengths: 0.3 milligrams (mg ...

Presented in a box that looks like a clinical journal, this demo kit lets retinal surgeons practice using the Lucentis Prefilled Syringe (ranibizumab) on a surgery-grade prosthetic eyeball. All judges ...

on a collaborative deal to develop a pre-filled syringe for delivering Eylea – only to have Vetter offer the same to Novartis for Lucentis. (Vetter had been providing vial-filling services for ...

Regeneron’s lawsuit alleged Vetter entered a similar arrangement with Novartis in 2009 to develop a prefilled syringe version of Lucentis, and that the companies schemed to restrict competition.

Novartis announces the launch in Europe of the Lucentis pre-filled syringe (PFS), which is specifically designed for intraocular injection The Lucentis PFS can lead to improved patient treatment ...

(Thomson Reuters ONE via COMTEX) -- Novartis International AG / Novartis introduces Lucentis(R) in state of the art pre-filled syringe . Processed and transmitted by NASDAQ OMX Corporate Solutions.

Basel, March 20, 2014-Novartis has announced the launch of the Lucentis ® (ranibizumab) pre-filled syringe (PFS) in Germany, with other markets to follow throughout 2014. The Lucentis PFS, which ...